Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |